Page last updated: 2024-08-16

resveratrol and Prostatic Neoplasms

resveratrol has been researched along with Prostatic Neoplasms in 122 studies

Research

Studies (122)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.46)	18.2507
2000's	43 (35.25)	29.6817
2010's	62 (50.82)	24.3611
2020's	14 (11.48)	2.80

Authors

Authors	Studies
Aktepe, N; Yukselten, Y	1
Arab, AR; El-Benhawy, SA; Fahmy, EI; Khalil, FAZF; Morsi, MI; Soula, MA	1
Chen, Y; Ghosh, R; Hu, M; Huang, SB; Kumar, AP; Lai, Z; Reddick, RL; Rivas, P; Schadler, KL; Yang, X	1
Chen, Y; Gao, D; Han, Y; Lin, Y; Lin, Z; Wang, F; Wang, P; Wang, Y; Yuan, H; Zhang, L	1
Dewangan, HK; Sharma, AN; Upadhyay, PK	1
Azeez, TA; Gordon, BS; La Favor, JD; Pierre, CJ; Rossetti, ML	1
Han, DS; Lee, EO; Lee, HJ	1
Jeon, D; Jo, M; Lee, Y; Nam, JH; Namkung, W; Park, SH; Phan, HTL	1
Bloebaum, P; Jurisson, SS; Katti, KK; Katti, KV; Khoobchandani, M; Panjtan Amiri, K; Raphael Karikachery, A; Thipe, VC	1
Dholakia, K; Kumar, A; Levenson, AS; Martinez, LA; Sikorska, G	1
Cao, Q; Chen, FZ; Chen, HC; Khusbu, FY; Roy, M; Zhou, X	1
Hsieh, TC; Wu, JM	2
Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I	1
Chen, Z; Fan, M; Feng, Y; Liang, B; Luo, G; Shi, J; Sun, Y; Wang, K; Xu, X; Yu, M; Zhuang, Q	1
Beretta, GL; Zaffaroni, N	1
Eroglu, E	1
Britton, RG; Brown, K; Cai, H; Khan, M; Malfatti, M; Ognibene, TJ; Parrott, E; Scott, EN; Steward, WP	1
Coppo, L; Gonzalez-Menendez, P; Hevia, D; Holmgren, A; Lu, J; Mayo, JC; Rodriguez-Garcia, A; Sainz, RM	1
Dash, AK; Saralkar, P	1
Al Aameri, RFH; Alanisi, EMA; Borse, V; Mukherjea, D; Ramkumar, V; Rybak, LP; Sheth, S	1
Kumar, A; Levenson, AS; Rimando, AM	1
Kumar, S; Manne, U; Mishra, MK; Scissum-Gunn, K; Singh, R; Singh, UP; Stokes, J	1
Chen, YR; Cheng, TM; Chin, YT; Davis, PJ; Ho, Y; Lin, HY; Lin, TI; Shih, YJ; Yang, YC; Yang, YN	1
Lillard, JW; Singh, R; Singh, SK	1
Christensen, M; Doughty, H; Kenealey, J; Lawson, J; Oblad, R	1
D'silva, M; Dholakia, K; Kumar, A; Levenson, AS	1
Gao, Z; Wang, D; Zhang, X	1
Chiloeches, A; Gallego, B; Gil-Araujo, B; Lasa, M; Martínez-Martínez, D; Soto, A	1
Casaburi, I; Chimento, A; De Amicis, F; Montalto, FI; Pezzi, V; Sirianni, R	1
Choi, KC; Go, RE; Hwang, KA; Jang, YG	1
Dhar, S; Dias, SJ; Levenson, AS; Lewin, JR; Li, K; Mizuno, CS; Penman, AD; Rimando, AM	1
Dhar, S; Dias, SJ; Levenson, AS; Li, K; Mizuno, CS; Penman, AD; Rimando, AM	1
Chang, HT; Chen, IL; Chou, CT; Huang, JK; Jan, CR; Kuo, DH; Liang, WZ; Shieh, P	1
Hadjipavlou, M; Khan, S; Philippou, Y; Rane, A	1
Mukhtar, H; Sanna, V; Sechi, M; Siddiqui, IA	1
Antal, A; Bommareddy, A; Eggleston, W; McCune, DF; Prelewicz, S; Vanwert, AL; Witczak, Z	1
Ahmad, N; Pitschmann, A; Singh, CK	1
Canapè, C; Catanzaro, G; Jensen, PR; Karlsson, M; Lerche, MH; Terreno, E	1
Cao, J; Chen, H; Chong, T; Li, H; Li, J; Wang, Z; Zhang, P	1
Djamgoz, MB; Fleming-Jones, S; Fraser, SP; Mukhey, D; Peters, A	1
Kumar, A; Levenson, AS; Zhang, X	1
Al-Taher, AY; El-Sheikh, AA; Morsy, MA	1
Dhar, S; Kumar, A; Levenson, AS; Li, K; Tzivion, G	1
Selvaraj, S; Singh, BB; Sukumaran, P; Sun, Y	1
Cohen, AS; Hougaard, DM; Jørgensen, JO; Kjaer, TN; Neghabat, S; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B	1
Dhar, S; Kumar, A; Lage, JM; Levenson, AS; Lewin, JR; Rimando, AM; Zhang, X	1
Dhar, S; Kumar, A; Levenson, AS; Rimando, AM; Zhang, X	1
Albers, M; Empl, MT; Steinberg, P; Wang, S	1
Biswas, PK; Butt, NA; Chakraborty, S; Kumar, A; Levenson, AS; Rimando, AM; Williams, R; Zhang, L	1
Kaplan, SA	1
Chang, SJ; Chen, CC; Chen, YA; Hsieh, JT; Kao, MC; Lai, CH; Lien, HM; Lin, CJ; Lin, H; Lin, LC; Lo, UG; Tang, CH	1
Eroglu, E; Kumar, S; Manne, U; Mishra, MK; Ponnazhagan, S; Saldanha, SN; Scissum-Gunn, K; Singh, UP; Stokes, JA	1
Bone, KM; Emery, J; Lusk, E; Pirotta, MV; Taylor, JM; van Die, MD; Williams, SG	1
Acosta, EP; Banerjee, S; Lillard, JW; Singh, R; Singh, SK	1
Allart, L; Bokhobza, A; Bonnal, JL; Delcourt, P; Derouiche, S; Desruelles, E; Dewailly, E; Gosset, P; Lemonnier, L; Mariot, P; Mauroy, B; Noyer, L; Prevarskaya, N; Roudbaraki, M; Sadofsky, LR; Slomianny, C; Vancauwenberghe, E; Warnier, M	1
Davies, NM; Hudson, TS; Hursting, SD; Kim, YS; Perkins, SN; Remsberg, CM; Seifried, H; Takahashi, Y; Vinyard, BT; Wang, TC; Wang, TT	1
Benitez, DA; Castellón, EA; Fernández-Salguero, PM; Hermoso, MA; Pozo-Guisado, E	1
Narayanan, BA; Narayanan, NK; Nargi, D; Randolph, C	1
Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L	1
Hsieh, TC	1
Arabshahi, A; Cook, LM; Eltoum, IA; Harper, CE; Lamartiniere, CA; Patel, BB; Shirai, T; Wang, J	1
Kai, L; Levenson, AS; Samuel, SK	1
Chen, HC; Cho, E; Farrell, J; Leong, M; Shi, WF; Tian, J; Zhang, D	1
Adhami, VM; Khan, N; Mukhtar, H	1
Kim, YS; Mizuno, CS; Rimando, AM; Schoene, NW; Wang, TT	1
Eng, C; He, X; Heston, WD; Orloff, MS; Romigh, T; Silverman, RH; Wang, Y	1
Hsieh, TC; Huang, YC; Wu, JM	1
Chen, Q; Ganapathy, S; Shankar, S; Singh, KP; Srivastava, RK	2
Culig, Z; Horndasch, M	1
Dhar, S; Hicks, C; Levenson, AS	1
Kai, L; Levenson, AS	1
Bristow, RG; Dayes, I; Liu, C; Lukka, H; Rashid, A; Sanli, T; Singh, G; Tsakiridis, T; Tsiani, E; Wright, J	1
Di Vizio, D; Freeman, MR; Kim, J; Lisanti, MP	1
Sato, S; Shirai, T; Takahashi, S	1
Hsieh, TC; Lee, YS; Lin, CY; Wu, JM; Yang, CJ	1
DeMarco, VG; Fang, Y; Nicholl, MB	1
Freedland, SJ; Masko, EM; Osmond, GW; Pizzo, S; Tyler, DS	1
Bubley, G; Klempner, SJ	1
Castelli, T; Cimino, S; Favilla, V; Madonia, M; Morgia, G; Russo, GI; Sansalone, S; Sortino, G	1
Adam, V; Busch, KH; Ekblad, M; Halldén, G; Johnsen, CT; Kang, NR; Lemoine, NR; Müller, H; Sweeney, K	1
Antonelli, J; Cohen, P; Dewhirst, MW; Febbo, PG; Freedland, SJ; Klink, JC; Masko, EM; Pizzo, SV; Tewari, AK	1
Bedolla, R; Ghosh, R; Kumar, AP; Li, G; Reddick, RL; Rivas, P; Thapa, D	1
Jajoo, S; Kaur, T; Mukherjea, D; Ramkumar, V; Rybak, LP; Sheehan, K; Sheth, S	1
Bennett, JA; Davis, FB; Davis, PJ; Lin, HY; Martino, LJ; Shih, A; Tang, HY	1
Beebe, SJ; Elliott, MS; Morris, GZ; Williams, RL	1
Chapman, RA; Deeb, D; Gao, X; Gautam, SC; Janakiraman, N; Jiang, H; Xu, YX	1
Narayanan, BA; Narayanan, NK; Nixon, DW; Re, GG	1
Artime, MC; O'Brian, CA; Stewart, JR	1
Debatin, KM; Fulda, S	1
O'Brian, CA; Stewart, JR	1
Choi, YH; Kim, YA; Park, KY; Rhee, SH	1
Gao, S; Liu, GZ; Wang, Z	1
Ghidoni, R; Macchia, M; Minutolo, F; Sacchi, N; Sala, G	1
Pan, Y; Young, CY; Yuan, H	1
Hsieh, TC; Ma, Y; Wang, Z; Wu, JM; Zhang, Z	1
Ansell, PJ; Browning, JD; Lubahn, DB; Macdonald, RS; Sakla, MS; Shenouda, NS; Zhou, C	1
Capasso, F; Cardile, V; Consoli, R; Renis, M; Russo, A; Scifo, C; Vancheri, C; Vanella, A	1
Boswell, S; Cao, HJ; Davis, FB; Davis, PJ; Lennartz, MR; Lin, HY; Shih, A; Tang, HY; Wu, YH; Zhang, S	1
Narayanan, BA; Narayanan, NK; Nixon, DW	1
Cardile, V; Lombardo, L; Spatafora, C; Tringali, C	1
Brooks, JD; DePrimo, SE; Jones, SB; Whitfield, ML	1
Guarnera, A; Milasi, A; Renis, M; Scifo, C; Sinatra, F	1
Choi, SY; Kim, KT; Kim, S; Kim, SS; Kim, SY; Moon, BK; Yoo, KM	1
Ahmad, N; Aziz, MH; Fu, VX; Jarrard, DF; Nihal, M	1
Botturi, M; Ghidoni, R; Maioli, C; Milani, F; Minella, M; Ricci, C; Sala, G; Scarlatti, F	1
Ahmad, KA; Ahmed, K; Harris, NH; Johnson, AD; Lindvall, HC; Wang, G	1
Benitez, DA; Castellón, E; Clementi, M; Fernandez-Salguero, PM; Pozo-Guisado, E	1
Wietrzyk, J	1
Shankar, S; Siddiqui, I; Srivastava, RK	1
Arabshahi, A; Eltoum, IA; Harper, CE; Lamartiniere, CA; Patel, BB; Wang, J	1
Djavan, B; Kuehhas, F; Marihart, S; Partin, A; Rom, M; Schalken, J; Sekeres, T	1
Arany, P; Green, JE; Hartle, DK; Hudson, TS; Hursting, SD; Nunez, NP; Wang, TT; Young, HA	1
Fitzpatrick, JM; Gill, C; Morrissey, C; Walsh, SE; Watson, RW	1
Chen, X; Djeu, JY; Gilvary, DL; Sallman, DA; Wei, S; Zhong, B; Zhou, J	1
Harada, N; Inui, H; Miura, T; Murata, Y; Nakano, Y; Yamaji, R	1
Jia, L; Kline, K; Sanders, BG; Snyder, RM; Yu, W	1
Baumgartner, G; Hamilton, G; Hejna, M; Hoffmann, O; Mallinger, R; Raderer, M; Ulsperger, E	1
Mitchell, SH; Young, CY; Zhu, W	1
Barrack, ER; Cifuentes, E; Gautam, S; Kuwajerwala, N; Menon, M; Reddy, GP	1
Bullock, BP; Narayanan, BA; Narayanan, NK; Stoner, GD	1

Reviews

13 review(s) available for resveratrol and Prostatic Neoplasms

Article	Year
Resveratrol and Prostate Cancer: The Power of Phytochemicals. Current medicinal chemistry, 2021, Volume: 28, Issue:24 Topics: Antineoplastic Agents; Humans; Male; Phytochemicals; Prostatic Neoplasms; Resveratrol	2021
Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer. Annals of the New York Academy of Sciences, 2017, Volume: 1403, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Chemoprevention; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Prostatic Neoplasms; Resveratrol; Stilbenes	2017
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer. International journal of molecular sciences, 2019, Mar-03, Volume: 20, Issue:5 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Prostatic Neoplasms; Receptors, Steroid; Resveratrol; Signal Transduction	2019
Complementary and alternative medicine (CAM) in prostate and bladder cancer. BJU international, 2013, Volume: 112, Issue:8 Topics: Acupuncture; Antineoplastic Agents; Antioxidants; Camellia sinensis; Complementary Therapies; Drugs, Chinese Herbal; Female; Humans; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Urinary Bladder Neoplasms; Vitamin E; Vitamins	2013
Chemoprevention of prostate cancer by major dietary phytochemicals. Anticancer research, 2013, Volume: 33, Issue:10 Topics: Animals; Anticarcinogenic Agents; Capsaicin; Carotenoids; Chemoprevention; Curcumin; Humans; Lycopene; Male; Phytochemicals; Prostatic Neoplasms; Resveratrol; Stilbenes	2013
MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities. Cancer metastasis reviews, 2014, Volume: 33, Issue:4 Topics: Animals; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Male; Mice; Molecular Targeted Therapy; Neovascularization, Pathologic; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Stilbenes; Trans-Activators	2014
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Archives of biochemistry and biophysics, 2009, Jun-15, Volume: 486, Issue:2 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors	2009
Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocrine-related cancer, 2010, Volume: 17, Issue:1 Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Carotenoids; Catechin; Clinical Trials as Topic; Curcumin; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Genistein; Humans; Lycopene; Lythraceae; Male; Mice; Mice, Nude; Mice, Transgenic; Middle Aged; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured	2010
[Chemoprevention of prostate cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 5 Topics: Animals; Anticarcinogenic Agents; Carotenoids; Curcumin; Humans; Isoflavones; Lycopene; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Vitamin E	2011
Complementary and alternative medicines in prostate cancer: from bench to bedside? The oncologist, 2012, Volume: 17, Issue:6 Topics: Antioxidants; Beverages; Complementary Therapies; Curcuma; Humans; Lythraceae; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Tea; Vitamin E; Vitamins	2012
Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxidative medicine and cellular longevity, 2012, Volume: 2012 Topics: Antioxidants; Catechin; Curcumin; Flavonoids; Genistein; Humans; Male; Polyphenols; Prostatic Neoplasms; Quercetin; Resveratrol; Stilbenes	2012
Resveratrol: a candidate nutritional substance for prostate cancer prevention. The Journal of nutrition, 2003, Volume: 133, Issue:7 Suppl Topics: Antineoplastic Agents, Phytogenic; Diet; ErbB Receptors; Flavonoids; Humans; Male; Phenols; Polymers; Polyphenols; Prostatic Neoplasms; Resveratrol; Stilbenes	2003
[The influence of isoflavonoids on the antitumor activity of vitamin D3]. Postepy higieny i medycyny doswiadczalnej (Online), 2007, Volume: 61 Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cholecalciferol; Colonic Neoplasms; Female; Humans; Isoflavones; Male; Mice; Prostatic Neoplasms; Receptors, Calcitriol; Resveratrol; Steroid Hydroxylases; Stilbenes; Tumor Cells, Cultured; Up-Regulation; Vitamin D3 24-Hydroxylase	2007

Trials

3 trial(s) available for resveratrol and Prostatic Neoplasms

Article	Year
Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34 Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult	2007
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men. The Prostate, 2015, Volume: 75, Issue:12 Topics: Aged; Androgens; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dihydrotestosterone; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Resveratrol; Stilbenes; Testosterone; Testosterone Congeners	2015
A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer. The Prostate, 2017, Volume: 77, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Behavioral Symptoms; Biomarkers, Tumor; Brassica; Curcuma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Radiotherapy; Resveratrol; Stilbenes; Symptom Assessment; Tea; Time Factors; Treatment Outcome	2017

Other Studies

106 other study(ies) available for resveratrol and Prostatic Neoplasms

Article	Year
Induction of apoptosis in human hormone-refractory prostate cancer cell lines by using resveratrol in combination with AT-101. Andrologia, 2022, Volume: 54, Issue:1 Topics: Apoptosis; Cell Line; Cell Line, Tumor; Gossypol; Hormones; Humans; Male; Prostatic Neoplasms; Resveratrol	2022
Role of Resveratrol as Radiosensitizer by Targeting Cancer Stem Cells in Radioresistant Prostate Cancer Cells (PC-3). Asian Pacific journal of cancer prevention : APJCP, 2021, Dec-01, Volume: 22, Issue:12 Topics: Biomarkers, Tumor; Cell Survival; Epithelial-Mesenchymal Transition; Humans; Male; Neoplastic Stem Cells; PC-3 Cells; Prostatic Neoplasms; Radiation-Sensitizing Agents; Resveratrol; Signal Transduction	2021
SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression. Molecular carcinogenesis, 2022, Volume: 61, Issue:7 Topics: Androgen Antagonists; Animals; Cellular Senescence; Humans; Male; Mice; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Resveratrol; Sirtuin 1	2022
Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2022, Jul-01, Volume: 174 Topics: Animals; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Humans; Liposomes; Male; Mice; Mice, Nude; Prostatic Neoplasms; Resveratrol	2022
Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting. Journal of microencapsulation, 2022, Volume: 39, Issue:6 Topics: Animals; Drug Carriers; Humans; Lipids; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Rats; Resveratrol; Tissue Distribution	2022
Long-term administration of resveratrol and MitoQ stimulates cavernosum antioxidant gene expression in a mouse castration model of erectile dysfunction. Life sciences, 2022, Dec-01, Volume: 310 Topics: Androgen Antagonists; Androgens; Animals; Antioxidants; Disease Models, Animal; Erectile Dysfunction; Gene Expression; Humans; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Penis; Prostatic Neoplasms; Resveratrol; Testosterone	2022
Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells. Scientific reports, 2022, 11-22, Volume: 12, Issue:1 Topics: Humans; Male; Matrix Metalloproteinase 2; PC-3 Cells; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger	2022
Inhibition of ANO1 by International journal of molecular sciences, 2023, Jan-07, Volume: 24, Issue:2 Topics: Anoctamin-1; Head and Neck Neoplasms; Humans; Male; Neoplasm Proteins; PC-3 Cells; Prostatic Neoplasms; Resveratrol	2023
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. International journal of nanomedicine, 2019, Volume: 14 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Shape; Cell Survival; Endocytosis; Female; Gold; Humans; Inhibitory Concentration 50; Male; Metal Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyphenols; Prostatic Neoplasms; Resveratrol; Spectrophotometry, Ultraviolet; Treatment Outcome	2019
MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer. Nutrients, 2019, Sep-04, Volume: 11, Issue:9 Topics: Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Stilbenes; Trans-Activators	2019
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration. The international journal of biochemistry & cell biology, 2020, Volume: 118 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Resveratrol; Snail Family Transcription Factors; Xenograft Model Antitumor Assays	2020
Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells. International journal of molecular sciences, 2020, Mar-04, Volume: 21, Issue:5 Topics: Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Male; Neoplasm Invasiveness; Phenotype; Prostate; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stromal Cells; Transcriptional Activation	2020
Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells. The Prostate, 2020, Volume: 80, Issue:12 Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Movement; DNA Methylation; HEK293 Cells; Humans; Male; Mixed Function Oxygenases; Neoplasm Invasiveness; PC-3 Cells; Prostatic Neoplasms; Proto-Oncogene Proteins; Resveratrol; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Up-Regulation	2020
A Resveratrol-Loaded Poly(2-hydroxyethyl methacrylate)-Chitosan Based Nanotherapeutic: Characterization and Journal of nanoscience and nanotechnology, 2021, 04-01, Volume: 21, Issue:4 Topics: Chitosan; Drug Carriers; Humans; Male; Methacrylates; Nanoparticles; Prostatic Neoplasms; Resveratrol	2021
Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a "dietary-achievable" or "pharmacological" dose: what are the implications for anticancer activity? The American journal of clinical nutrition, 2021, 05-08, Volume: 113, Issue:5 Topics: Administration, Oral; Antioxidants; Carbon Radioisotopes; Cell Line, Tumor; Diet; Dose-Response Relationship, Drug; Drug Administration Routes; Humans; Isotope Labeling; Male; Prostate; Prostatic Neoplasms; Resveratrol	2021
Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells. Redox biology, 2017, Volume: 12 Topics: Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Survival; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Male; Melatonin; Prostatic Neoplasms; Reactive Oxygen Species; Resveratrol; Silybin; Silymarin; Stilbenes; Thioredoxins	2017
Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line. AAPS PharmSciTech, 2017, Volume: 18, Issue:7 Topics: Alginates; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Resveratrol; Stilbenes	2017
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PloS one, 2017, Volume: 12, Issue:5 Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Interleukin-6; Male; MicroRNAs; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Long Noncoding; Signal Transduction; STAT3 Transcription Factor; Stilbenes	2017
Prolonged exposure of resveratrol induces reactive superoxide species-independent apoptosis in murine prostate cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:10 Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Male; Membrane Potential, Mitochondrial; Mice; Prostatic Neoplasms; Reactive Oxygen Species; Resveratrol; Stilbenes	2017
Resveratrol induces sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 112 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclooxygenase 2; Enzyme Induction; Gene Knockdown Techniques; Humans; Male; MAP Kinase Signaling System; Microscopy, Confocal; Phosphorylation; Prostatic Neoplasms; Protein Transport; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Small Interfering; Stilbenes; SUMO-1 Protein; Sumoylation; Tumor Suppressor Protein p53	2018
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer letters, 2018, 07-28, Volume: 427 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Resveratrol	2018
Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells. Molecular pharmacology, 2018, Volume: 94, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxolanes; Docetaxel; Drug Synergism; Flavonoids; Humans; Male; Mitoxantrone; Models, Statistical; Piperidines; Prostatic Neoplasms; Resveratrol; Taxoids	2018
In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer. Nutrients, 2018, Nov-20, Volume: 10, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoprevention; Colony-Forming Units Assay; Flavonoids; Histone Deacetylases; Humans; Male; Plant Extracts; Powders; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Stilbenes; Trans-Activators; Vitis; Wound Healing	2018
Resveratrol Induces Apoptosis in Murine Prostate Cancer Cells via Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Reactive Oxygen Species (ROS)/P53 Signaling. Medical science monitor : international medical journal of experimental and clinical research, 2018, Dec-11, Volume: 24 Topics: Animals; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; China; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Resveratrol; Signal Transduction; Tumor Suppressor Protein p53	2018
Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2019, Volume: 124 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cisplatin; Cyclooxygenase 2; Down-Regulation; Drug Synergism; Dual Specificity Phosphatase 1; G2 Phase Cell Cycle Checkpoints; Humans; Male; NF-kappa B; PC-3 Cells; Prostatic Neoplasms; Resveratrol; Up-Regulation	2019
Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. The Journal of steroid biochemistry and molecular biology, 2019, Volume: 192 Topics: Androgen Receptor Antagonists; Androgens; Antioxidants; Apoptosis; Cell Movement; Cell Proliferation; Dihydrotestosterone; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Receptors, CXCR4; Resveratrol; Signal Transduction; Tumor Cells, Cultured	2019
Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PloS one, 2013, Volume: 8, Issue:3 Topics: Acetylation; Animals; Antineoplastic Agents, Phytogenic; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases; Male; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Mice; Neoplasm Metastasis; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Signal Transduction; Stilbenes; Trans-Activators; Transcription Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2013
Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. The Prostate, 2013, Volume: 73, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Growth Inhibitors; Male; Mice; Mice, Nude; Prostatic Neoplasms; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays	2013
Mechanisms of resveratrol-induced changes in [Ca(2+)]i and cell viability in PC3 human prostate cancer cells. Journal of receptor and signal transduction research, 2013, Volume: 33, Issue:5 Topics: Apoptosis; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Proliferation; Cell Survival; Homeostasis; Humans; Male; Phorbols; Prostatic Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Resveratrol; Stilbenes	2013
Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Molecular pharmaceutics, 2013, Oct-07, Volume: 10, Issue:10 Topics: Cell Line, Tumor; Cell Survival; Humans; Magnetic Resonance Spectroscopy; Male; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Polyesters; Prostatic Neoplasms; Resveratrol; Spectroscopy, Fourier Transform Infrared; Stilbenes	2013
Resveratrol-zinc combination for prostate cancer management. Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:12 Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Homeostasis; Humans; Male; Prostate; Prostatic Neoplasms; Resveratrol; Stilbenes; Trace Elements; Zinc	2014
Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine. Magnetic resonance in medicine, 2015, Volume: 73, Issue:6 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carbon Isotopes; Cells, Cultured; Chromatography, High Pressure Liquid; Contrast Media; Enzyme-Linked Immunosorbent Assay; Gadolinium; Glutamine; Heterocyclic Compounds; Humans; In Vitro Techniques; Isothiocyanates; Magnetic Resonance Spectroscopy; Male; Organometallic Compounds; Phenotype; Prostatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides	2015
A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells. Molecular medicine reports, 2014, Volume: 10, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Hedgehog Proteins; Humans; Lipopolysaccharides; Male; Prostatic Neoplasms; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Transcription Factors; Vimentin; Zinc Finger Protein GLI1	2014
Resveratrol: inhibitory effects on metastatic cell behaviors and voltage-gated Na⁺ channel activity in rat prostate cancer in vitro. Nutrition and cancer, 2014, Volume: 66, Issue:6 Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Male; Neoplasm Metastasis; Prostatic Neoplasms; Rats; Resveratrol; Sodium Channel Blockers; Sodium Channels; Stilbenes; Tetrodotoxin	2014
Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage. Life sciences, 2014, Dec-05, Volume: 119, Issue:1-2 Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Body Weight; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Male; Methotrexate; Multidrug Resistance-Associated Proteins; Prostatic Neoplasms; Protective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Testis; Testosterone	2014
Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochimica et biophysica acta, 2015, Volume: 1853, Issue:2 Topics: Acetylation; Animals; Cell Line, Tumor; Cell Nucleus; Down-Regulation; Enzyme Activation; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Immunoprecipitation; Male; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Mice, Nude; Models, Biological; Nucleosomes; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Repressor Proteins; Resveratrol; Signal Transduction; Stilbenes; Trans-Activators; Up-Regulation; Xenograft Model Antitumor Assays	2015
Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Molecular carcinogenesis, 2016, Volume: 55, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Autophagy; Calcium; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Membrane Proteins; Neoplasm Proteins; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes; Stromal Interaction Molecule 1; TOR Serine-Threonine Kinases	2016
Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Annals of the New York Academy of Sciences, 2015, Volume: 1348, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Male; MicroRNAs; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Stilbenes; Trans-Activators; Xenograft Model Antitumor Assays	2015
Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget, 2015, Sep-29, Volume: 6, Issue:29 Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Lentivirus; Luciferases; Male; Mice; MicroRNAs; Prostatic Neoplasms; PTEN Phosphohydrolase; Resveratrol; RNA, Messenger; Stilbenes	2015
The Resveratrol Tetramer r-Viniferin Induces a Cell Cycle Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP. Phytotherapy research : PTR, 2015, Volume: 29, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; G1 Phase; Growth Inhibitors; Humans; Male; Polyphenols; Prostatic Neoplasms; Resveratrol; Stilbenes	2015
Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions. Molecular bioSystems, 2016, Volume: 12, Issue:5 Topics: Androgen Antagonists; Cell Line, Tumor; Computer Simulation; Flutamide; Humans; Hydrogen Bonding; Male; Molecular Conformation; Molecular Dynamics Simulation; Mutant Proteins; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Resveratrol; Stilbenes; Thermodynamics	2016
Re: Resveratrol Reduces the Levels of Circulating Androgen Precursors but has No Effect on Testosterone, Dihydrotestosterone, PSA Levels or Prostate Volume. A 4-Month Randomised Trial in Middle-Aged Men. The Journal of urology, 2016, Volume: 195, Issue:6 Topics: Androgens; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Resveratrol; Stilbenes; Testosterone	2016
Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems. PloS one, 2017, Volume: 12, Issue:1 Topics: Animals; Apoptosis; Arachis; Cell Line, Tumor; Chemoradiotherapy; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Plant Stems; Prostatic Neoplasms; Radiation Tolerance; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays	2017
Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells. Oncotarget, 2017, Mar-28, Volume: 8, Issue:13 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Caspases; Cell Cycle Proteins; Cell Proliferation; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2017
Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget, 2017, Mar-07, Volume: 8, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Docetaxel; Drug Synergism; Humans; Immunoblotting; Male; Microscopy, Fluorescence; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes; Taxoids; Tumor Suppressor Protein p53	2017
Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF). Molecular carcinogenesis, 2017, Volume: 56, Issue:8 Topics: Amino Acid Sequence; Anticarcinogenic Agents; Antioxidants; Apoptosis; Calcium; Calcium Channels; Cancer-Associated Fibroblasts; Cell Line, Tumor; Humans; Male; Mutation; Nerve Tissue Proteins; Prostate; Prostatic Neoplasms; Resveratrol; Stilbenes; Transient Receptor Potential Channels; TRPA1 Cation Channel; Tumor Microenvironment	2017
Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis, 2008, Volume: 29, Issue:10 Topics: Androgens; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Estradiol; Gene Expression Profiling; Humans; Male; Metribolone; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptor, IGF Type 1; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Transplantation, Heterologous	2008
Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. The Prostate, 2009, Jul-01, Volume: 69, Issue:10 Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; NF-kappa B; Prostatic Neoplasms; Protein Subunits; Resveratrol; Signal Transduction; Stilbenes; Subcellular Fractions; Transcription Factor RelA	2009
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. International journal of cancer, 2009, Jul-01, Volume: 125, Issue:1 Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carrier Proteins; Cell Cycle; Cell Proliferation; Curcumin; Cyclin D1; Disease Progression; Drug Carriers; Drug Delivery Systems; Incidence; Liposomes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Androgen; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases	2009
Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. Anticancer research, 2009, Volume: 29, Issue:8 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Male; Prostatic Neoplasms; Quinone Reductases; Receptors, Androgen; Resveratrol; RNA, Small Interfering; Stilbenes	2009
Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. The Prostate, 2009, Nov-01, Volume: 69, Issue:15 Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antigens, Polyomavirus Transforming; Apoptosis; Cell Growth Processes; Genistein; Histone Acetyltransferases; Immunohistochemistry; Insulin-Like Growth Factor I; Ki-67 Antigen; Male; Nuclear Receptor Coactivator 3; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Resveratrol; Stilbenes; Trans-Activators	2009
Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. International journal of cancer, 2010, Apr-01, Volume: 126, Issue:7 Topics: Acetylation; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p21; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Immunoprecipitation; Male; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Nucleosomes; Promoter Regions, Genetic; Prostatic Neoplasms; Repressor Proteins; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Stilbenes; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2010
Repressive effects of resveratrol on androgen receptor transcriptional activity. PloS one, 2009, Oct-09, Volume: 4, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chromatin Immunoprecipitation; DNA, Complementary; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Resveratrol; Stilbenes; Transcription, Genetic; Transcriptional Activation	2009
Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Molecular nutrition & food research, 2010, Volume: 54, Issue:3 Topics: Androgen Antagonists; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Resveratrol; RNA, Messenger; Stilbenes; Structure-Activity Relationship	2010
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Human molecular genetics, 2010, Nov-15, Volume: 19, Issue:22 Topics: Androgen Antagonists; Androgens; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Formazans; Gene Expression Regulation, Neoplastic; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Androgen; Resveratrol; Signal Transduction; Stilbenes; Tetrazolium Salts; Time Factors	2010
Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro. Carcinogenesis, 2011, Volume: 32, Issue:1 Topics: Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; DNA Damage; DNA Repair; Gene Expression; Humans; Male; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes	2011
Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PloS one, 2010, Dec-14, Volume: 5, Issue:12 Topics: Androstadienes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromones; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Male; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Wortmannin	2010
Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PloS one, 2010, 12-28, Volume: 5, Issue:12 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Flavonoids; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Ki-67 Antigen; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Phenols; Polyphenols; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand	2010
SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells. The Prostate, 2011, Volume: 71, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Down-Regulation; Humans; Male; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; RNA, Small Interfering; Stilbenes; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation	2011
Resveratrol and prostate cancer: promising role for microRNAs. Molecular nutrition & food research, 2011, Volume: 55, Issue:8 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Male; MicroRNAs; Prostatic Neoplasms; PTEN Phosphohydrolase; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes	2011
Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. Anticancer research, 2011, Volume: 31, Issue:10 Topics: Androgen Antagonists; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cycloheximide; Dihydrotestosterone; Down-Regulation; Drug Synergism; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Receptors, Androgen; Resveratrol; RNA, Messenger; Stilbenes; Transcriptional Activation	2011
Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiation oncology (London, England), 2011, Oct-26, Volume: 6 Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; G1 Phase; Humans; Male; Microscopy, Fluorescence; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Radiation, Ionizing; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases	2011
A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death. Cancer biology & therapy, 2011, Dec-01, Volume: 12, Issue:11 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Butadienes; Cell Death; Cell Line, Tumor; Chlorocebus aethiops; Enzyme Inhibitors; Glutamine; Humans; Male; Mitochondria; Nitriles; Prostatic Neoplasms; Resveratrol; Stilbenes	2011
Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Carcinogenesis, 2012, Volume: 33, Issue:3 Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Quinone Reductases; Resveratrol; Retinoblastoma Protein; RNA Interference; RNA, Small Interfering; Stilbenes	2012
Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer science, 2012, Volume: 103, Issue:6 Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin B; Cyclin D; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p21; Fas Ligand Protein; Histones; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; Stilbenes; Tumor Suppressor Protein p53	2012
In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. The Journal of surgical research, 2013, Volume: 179, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Melanoma; Mice; Mice, Nude; Prostatic Neoplasms; Resveratrol; Skin Neoplasms; Stilbenes; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays	2013
Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models. Human gene therapy, 2012, Volume: 23, Issue:9 Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Dietary Supplements; Equol; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oncolytic Viruses; Phytoestrogens; Prostatic Neoplasms; Resveratrol; Stilbenes; Transplantation, Heterologous	2012
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. The Prostate, 2013, Volume: 73, Issue:7 Topics: Animals; Antioxidants; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Male; Mice; Mice, SCID; Proportional Hazards Models; Prostatic Neoplasms; Resveratrol; Stilbenes; Survival Analysis; Xenograft Model Antitumor Assays	2013
Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis. Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:1 Topics: Animal Feed; Animals; Cell Line, Tumor; Cell Survival; Diet; Humans; Immunohistochemistry; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Mutation; Phosphorylation; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Resveratrol; Ribosomal Protein S6 Kinases; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors; TOR Serine-Threonine Kinases	2013
Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PloS one, 2012, Volume: 7, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Enzyme Inhibitors; Estrogens; Flow Cytometry; Genes, Tumor Suppressor; Humans; Male; Mice; Mice, SCID; MicroRNAs; Morpholines; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotides; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Resveratrol; RNA, Small Interfering; Stilbenes; Wound Healing	2012
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. The Journal of urology, 2002, Volume: 168, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; DNA Mutational Analysis; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Prostatic Neoplasms; Proto-Oncogene Proteins p21(ras); Resveratrol; RNA, Messenger; Serine; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2002
Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. The Prostate, 2002, Sep-01, Volume: 52, Issue:4 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Survival; Diethylstilbestrol; Estrogens, Non-Steroidal; Humans; Hydroxyl Radical; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured	2002
Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Molecular cancer therapeutics, 2003, Volume: 2, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspases; Cell Survival; Curcumin; Humans; Male; Membrane Glycoproteins; Prostatic Neoplasms; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2003
Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. International journal of cancer, 2003, Mar-20, Volume: 104, Issue:2 Topics: Acetyltransferases; Apoptosis; Apoptotic Protease-Activating Factor 1; Cell Cycle Proteins; Flow Cytometry; G1 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Humans; Male; NF-kappa B; Oligonucleotide Array Sequence Analysis; p300-CBP Transcription Factors; Prostatic Neoplasms; Proteins; Resveratrol; Stilbenes; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2003
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer research, 2004, Jan-01, Volume: 64, Issue:1 Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Brain Neoplasms; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Primers; Female; Humans; Male; Melanoma; Membrane Glycoproteins; Pancreatic Neoplasms; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2004
Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Investigational new drugs, 2004, Volume: 22, Issue:2 Topics: Androgens; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; Isoenzymes; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-alpha; Resveratrol; Stilbenes	2004
Antiproliferative effect of resveratrol in human prostate carcinoma cells. Journal of medicinal food, 2003,Winter, Volume: 6, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Caspases; Cell Division; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation	2003
Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. The Prostate, 2004, May-01, Volume: 59, Issue:2 Topics: Amino Acid Sequence; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genistein; Humans; Male; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-raf; Receptors, Androgen; Resveratrol; Signal Transduction; Stilbenes; Transfection	2004
Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs under experimental and clinical research, 2003, Volume: 29, Issue:5-6 Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Ceramides; Humans; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship; Time Factors	2003
Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer letters, 2004, Sep-30, Volume: 213, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Humans; Male; Phenols; Prostatic Neoplasms; Proto-Oncogene Proteins c-jun; Quercetin; Receptors, Androgen; Resveratrol; Stilbenes; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation	2004
Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochemical and biophysical research communications, 2004, Oct-22, Volume: 323, Issue:3 Topics: Adsorption; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, Affinity; Drug Delivery Systems; Drug Evaluation, Preclinical; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Protein Binding; Protein Interaction Mapping; Resveratrol; Stilbenes	2004
Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutrition and cancer, 2004, Volume: 49, Issue:2 Topics: Antineoplastic Agents, Hormonal; Catechin; Cell Cycle; Cell Division; Curcumin; DNA Fragmentation; Humans; Male; Phytoestrogens; Prostatic Neoplasms; Quercetin; Receptors, Estrogen; Resveratrol; Stilbenes; Tumor Cells, Cultured	2004
Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncology research, 2004, Volume: 14, Issue:9 Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Male; Necrosis; Propolis; Prostatic Neoplasms; Reactive Oxygen Species; Resveratrol; Stilbenes	2004
Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. Molecular cancer therapeutics, 2004, Volume: 3, Issue:11 Topics: Apoptosis; Cell Line, Tumor; Enzyme Activation; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53	2004
Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation. Cancer detection and prevention, 2004, Volume: 28, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Electrophoresis, Polyacrylamide Gel; Humans; Male; Mass Spectrometry; Phosphoglycerate Mutase; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured	2004
Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorganic chemistry, 2005, Volume: 33, Issue:1 Topics: Anticarcinogenic Agents; Candida; Catalysis; Cell Division; Fibroblasts; Humans; Hydrogenation; Lipase; Male; Methylation; Molecular Structure; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured	2005
Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005, Volume: 14, Issue:3 Topics: Androgens; Antineoplastic Agents, Phytogenic; Cell Cycle; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Resveratrol; Stilbenes; Transcription, Genetic; Tumor Cells, Cultured; Wine	2005
Resveratrol and propolis extract: an insight into the morphological and molecular changes induced in DU145 cells. Oncology research, 2006, Volume: 15, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Therapy, Combination; Flow Cytometry; Humans; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Propolis; Prostatic Neoplasms; Resveratrol; Stilbenes	2006
Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells. Archiv der Pharmazie, 2006, Volume: 339, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Humans; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured	2006
Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Molecular cancer therapeutics, 2006, Volume: 5, Issue:5 Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Humans; Male; Microscopy, Fluorescence; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes	2006
Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer letters, 2007, Aug-08, Volume: 253, Issue:1 Topics: Cell Death; Cell Line, Tumor; Ceramides; Humans; Male; Prostatic Neoplasms; Radiation-Sensitizing Agents; Resveratrol; Stilbenes	2007
Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells. Molecular cancer therapeutics, 2007, Volume: 6, Issue:3 Topics: Apoptosis; Casein Kinase II; Caspase 3; Catechin; Cell Proliferation; Drug Therapy, Combination; Humans; Immunoblotting; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured	2007
Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. British journal of cancer, 2007, May-21, Volume: 96, Issue:10 Topics: Breast Neoplasms; Glycogen Synthase Kinase 3; Humans; Male; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured	2007
Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Molecular and cellular biochemistry, 2007, Volume: 304, Issue:1-2 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Caspases; Cell Survival; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Neoplasm; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured	2007
Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis, 2007, Volume: 28, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Crosses, Genetic; Disease Progression; Female; Heterozygote; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Resveratrol; Stilbenes	2007
[Resveratrol and newly synthetized resveratrol analogs in therapy of prostate carcinoma]. Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Humans; Male; Prostatic Neoplasms; Resveratrol; S Phase; Stilbenes; Structure-Activity Relationship; Tumor Stem Cell Assay	2007
Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer research, 2007, Sep-01, Volume: 67, Issue:17 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cellular Senescence; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Oncogene Protein v-akt; Oncogene Proteins; Plant Extracts; Prostatic Neoplasms; Protein Deglycase DJ-1; Protein Processing, Post-Translational; Resveratrol; Seeds; Signal Transduction; Stilbenes; Tumor Cells, Cultured; Vitis	2007
Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. The Prostate, 2007, Nov-01, Volume: 67, Issue:15 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Chromones; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Gene Silencing; Humans; Inhibitor of Apoptosis Proteins; Male; Morpholines; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, Death Domain; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Ubiquitin-Protein Ligases	2007
Clusterin mediates TRAIL resistance in prostate tumor cells. Molecular cancer therapeutics, 2007, Volume: 6, Issue:11 Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Clusterin; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinases; Male; Prostatic Neoplasms; Proto-Oncogene Proteins pp60(c-src); Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; RNA, Small Interfering; STAT Transcription Factors; Stilbenes; Taxoids; TNF-Related Apoptosis-Inducing Ligand	2007
Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. Journal of nutritional science and vitaminology, 2007, Volume: 53, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; Resveratrol; Stilbenes	2007
Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutrition and cancer, 2008, Volume: 60, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Resveratrol; Stilbenes; Tocopherols; Vitamin E	2008
Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Experimental cell research, 1999, May-25, Volume: 249, Issue:1 Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Division; Flow Cytometry; G1 Phase; Gene Expression Regulation; Growth Inhibitors; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured	1999
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants. International journal of oncology, 1999, Volume: 15, Issue:5 Topics: Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Renal Cell; Cell Differentiation; Cell Line; Culture Media, Conditioned; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Kidney Neoplasms; Lung; Male; Osteoblasts; Pancreatic Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured	1999
Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer research, 1999, Dec-01, Volume: 59, Issue:23 Topics: Antineoplastic Agents, Phytogenic; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Male; Nuclear Receptor Coactivators; Oncogene Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Resveratrol; RNA, Messenger; Stilbenes; Tissue Kallikreins; Trans-Activators; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation	1999
Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer research, 2002, May-01, Volume: 62, Issue:9 Topics: Androgens; Animals; Antineoplastic Agents, Phytogenic; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Humans; Male; Mice; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Resveratrol; S Phase; Stilbenes; Tumor Suppressor Proteins	2002
Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life sciences, 2002, Mar-01, Volume: 70, Issue:15 Topics: Anticarcinogenic Agents; Antioxidants; Carcinoma; DNA, Neoplasm; Ellagic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Phenols; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured	2002